Avenue Therapeutics, Inc.
ATXI
$0.252
$0.00190.76%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.64M | 4.74M | 5.08M | 4.51M | 4.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.28M | 11.81M | 10.72M | 11.82M | 14.54M |
| Operating Income | -11.28M | -11.81M | -10.72M | -11.82M | -14.54M |
| Income Before Tax | -11.70M | -9.52M | -5.92M | -7.24M | -10.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.70 | -9.52 | -5.92 | -7.24 | -10.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 44.00K | 52.00K | 54.00K | 54.00K | 111.00K |
| Net Income | -11.65M | -9.47M | -5.87M | -7.18M | -10.38M |
| EBIT | -11.28M | -11.81M | -10.72M | -11.82M | -14.54M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -19.92 | -21.46 | -14.67 | -46.98 | -133.15 |
| Normalized Basic EPS | -8.03 | -6.06 | -1.77 | -24.45 | -82.77 |
| EPS Diluted | -19.92 | -21.46 | -14.67 | -46.98 | -133.15 |
| Normalized Diluted EPS | -8.03 | -6.06 | -1.77 | -24.45 | -82.77 |
| Average Basic Shares Outstanding | 5.18M | 3.56M | 2.07M | 1.05M | 564.60K |
| Average Diluted Shares Outstanding | 5.18M | 3.56M | 2.07M | 1.05M | 564.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |